Fenofibrate Oral Suspension (Anhydrous)
Fenofibrate is used to lower high blood triglyceride levels (hypertriglyceridemia) in dogs. By reducing triglycerides and cholesterol, fenofibrate can help lower the risk of pancreatitis and manage metabolic complications associated with high lipid levels.
How to Give Anhydrous Oral Suspension
Oral Suspension (Anhydrous) is a liquid medication that does not contain water in its base. This might be an oil-based or other special base to help stabilize the medicine. It will look like a regular liquid medication, but often needs a good shake because the drug can settle. Here's how to give it:
- Shake well each time to mix the medication (5-10 seconds).
- Measure the dose using the syringe/dropper provided or one recommended by your vet. Insert the top of the oral syringe into the bottle adapter. Turn the bottle upside down and pull the plunger until the medicine reaches the volume required
- Hold your pet steady: a towel or helper can assist with squirmy pets.
- Administer the dose slowly into the side of the mouth. Allow small pauses if needed for swallowing.
- Raise the head slightly to help the medication go down and clean any spills with a little water or tissue.
- Praise your pet and offer a treat or water (unless advised against feeding right after).
- Clean the syringe with water immediately after use. Store the bottle as directed, out of sunlight.
- Consistency is key: Shake each time, measure accurately, and contact your vet if any issues arise.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Fenofibrate is a fibric acid derivative utilized in veterinary medicine for the management of lipid levels. It is a prescription medication available for use in dogs and cats, frequently considered by veterinarians for patients presented with inappropriately elevated blood triglycerides. The decision to select fenofibrate is typically based on diagnostic findings from a lipid profile in the context of metabolic health.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
At a pharmacological level, fenofibrate manages lipid metabolism by activating peroxisome proliferator-activated receptor alpha (PPARα). This mechanism manages the expression of genes involved in fatty acid oxidation and triglyceride clearance. Commonly observed effects include localized digestive changes such as vomiting or diarrhea. Because it can influence liver enzymes and muscle health, your veterinarian will monitor for observational signs of sensitivity or weakness. Owners should monitor their pet for any unusual behavioral shifts and contact their veterinarian promptly with any concerns.
Yes. Fenofibrate is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab verifies all professional authorizations before preparing any medication.
Yes. Mixlab specializes in compounding fenofibrate into customized strengths and flavored oral formats, such as flavored oral liquids, to suit the specific needs of your pet. The decision rests with your prescribing veterinarian.
Veterinarians discuss fenofibrate because it manages the body's ability to clear fats from the blood. This provides a method for addressing metabolic challenges that can influence overall organ health.
Your veterinarian will recommend periodic blood tests to monitor lipid levels, liver enzymes and muscle markers. This monitoring ensures the management approach remains safe for your pet's health status.
Some fenofibrate formulations are better absorbed when given with a meal. Your veterinarian will provide specific guidance on the most appropriate administration schedule for your pet.
